Paper17547312
Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
Vo AH and 6 others. Aviat Space Environ Med, 2007. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. Papers, record 17547312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547312
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Migraine Disorders | Major topic |
| Neuromuscular Agents | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Analysis of Variance | |
| Chi-Square Distribution | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Military Medicine | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01226706 | Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence | Background |
Source ClinicalTrials.gov
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39679425 | The Efficacy of Botulinum Toxin Use in Service Members and Veterans with Migraine and Post-Traumatic Headache Disorders: A Scoping Review. | J Pain Res | 2024 | https://conductscience.org/library/papers/39679425 | PubMed |
| 37235366 | Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/37235366 | PubMed |
| 36136557 | Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136557 | PubMed |
| 31398813 | Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/31398813 | PubMed |
| 31315864 | Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. | BMJ Open | 2019 | https://conductscience.org/library/papers/31315864 | PubMed |
| 29939406 | Botulinum toxins for the prevention of migraine in adults. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29939406 | PubMed |
| 28382110 | Botulinum toxin in the management of chronic migraine: clinical evidence and experience. | Ther Adv Neurol Disord | 2017 | https://conductscience.org/library/papers/28382110 | PubMed |
| 24819339 | Therapeutic use of botulinum toxin in migraine: mechanisms of action. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24819339 | PubMed |
| 22331030 | Chronic migraine--classification, characteristics and treatment. | Nat Rev Neurol | 2012 | https://conductscience.org/library/papers/22331030 | PubMed |
| 22275844 | Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. | Neuropsychiatr Dis Treat | 2012 | https://conductscience.org/library/papers/22275844 | PubMed |
| 20931348 | Are the current IHS guidelines for migraine drug trials being followed? | J Headache Pain | 2010 | https://conductscience.org/library/papers/20931348 | PubMed |
| 20159899 | Prophylaxis of migraine headache. | CMAJ | 2010 | https://conductscience.org/library/papers/20159899 | PubMed |
| 19750179 | The pharmacological management of migraine, part 2: preventative therapy. | P T | 2008 | https://conductscience.org/library/papers/19750179 | PubMed |
| 18095750 | Botulinum toxin for pain. | Drugs R D | 2008 | https://conductscience.org/library/papers/18095750 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17547312
GET https://conductscience.org/api/papers/v1/17547312/authors